Alterations in glycolysis can serve as biomarkers for infectious diseases. For instance, elevated lactate levels may indicate increased glycolytic activity in infections like sepsis. Metabolic profiling of glycolytic intermediates can aid in diagnosing and monitoring disease progression and treatment efficacy.
